S
SynAct Pharma AB
STO:SYNACT
SynAct Pharma AB
STO:SYNACT
Price:
17.32
SEK
Market Closed
Market Cap:
kr923.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
SynAct Pharma AB
STO:SYNACT
|
SE |
|
Salcef Group SpA
MIL:SCF
|
IT |
|
Sourcebio International PLC
LSE:SBI
|
UK |
|
U
|
U Power Ltd
NASDAQ:UCAR
|
CN |
|
J
|
JFB Construction Holdings
NASDAQ:JFB
|
US |
|
Bowlero Corp
NYSE:BOWL
|
US |
|
A
|
Astra Graphia Tbk PT
IDX:ASGR
|
ID |
|
P
|
Procorp SAB de CV
BMV:PROCORPB
|
MX |
|
M
|
Myomo Inc
AMEX:MYO
|
US |
|
C
|
Componenta Oyj
OMXH:CTH1V
|
FI |
|
B
|
B Communications Ltd
TASE:BCOM
|
IL |
|
Ops Ecom SpA
MIL:OEC
|
IT |
|
Blue Ant Media Corp
TSX:BAMI
|
CA |
|
Q
|
Qiagen NV
XETRA:QIA
|
NL |
|
O
|
Ourpalm Co Ltd
SZSE:300315
|
CN |
|
Cincinnati Financial Corp
NASDAQ:CINF
|
US |
|
Shenzhen Ridge Engineering Consulting Co Ltd
SZSE:300977
|
CN |
Cash Flow Statement
Cash Flow Statement
SynAct Pharma AB
SynAct Pharma AB
Currency: SEK
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||
| Net Income |
(77)
|
(85)
|
(96)
|
(101)
|
(106)
|
(142)
|
(159)
|
(164)
|
(224)
|
(192)
|
(168)
|
(160)
|
(90)
|
(92)
|
(104)
|
(115)
|
(117)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
75
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
0
|
0
|
0
|
10
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
0
|
0
|
1
|
1
|
(0)
|
1
|
7
|
10
|
10
|
95
|
92
|
90
|
10
|
3
|
(0)
|
(1)
|
6
|
|
| Cash Taxes Paid |
(5)
|
(5)
|
(5)
|
(5)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
0
|
0
|
0
|
(8)
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
|
| Change in Working Capital |
12
|
13
|
3
|
(15)
|
(13)
|
9
|
23
|
52
|
39
|
16
|
(7)
|
(21)
|
(10)
|
(17)
|
15
|
24
|
14
|
|
| Cash from Operating Activities |
(65)
N/A
|
(72)
-10%
|
(92)
-29%
|
(116)
-25%
|
(118)
-2%
|
(131)
-11%
|
(129)
+2%
|
(102)
+21%
|
(100)
+2%
|
(81)
+19%
|
(82)
-2%
|
(92)
-11%
|
(89)
+3%
|
(107)
-20%
|
(89)
+16%
|
(91)
-2%
|
(97)
-7%
|
|
| Investing Cash Flow | ||||||||||||||||||
| Other Items |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+1 250%
|
0
+874%
|
0
+50%
|
0
+1%
|
0
-7%
|
0
-64%
|
0
-99%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | ||||||||||||||||||
| Net Issuance of Common Stock |
80
|
0
|
0
|
0
|
229
|
0
|
0
|
0
|
59
|
0
|
0
|
0
|
94
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(0)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
|
| Other |
(6)
|
(0)
|
125
|
125
|
(27)
|
201
|
75
|
75
|
(5)
|
54
|
102
|
102
|
(6)
|
107
|
96
|
131
|
90
|
|
| Cash from Financing Activities |
74
N/A
|
(0)
N/A
|
125
N/A
|
125
0%
|
201
+61%
|
201
0%
|
75
-62%
|
75
+0%
|
54
-28%
|
54
+0%
|
102
+88%
|
102
+0%
|
87
-14%
|
107
+23%
|
96
-11%
|
131
+37%
|
90
-31%
|
|
| Change in Cash | ||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
(0)
|
2
|
1
|
1
|
1
|
1
|
0
|
(0)
|
0
|
(1)
|
(0)
|
1
|
(1)
|
(0)
|
(0)
|
(1)
|
|
| Net Change in Cash |
9
N/A
|
(72)
N/A
|
34
N/A
|
10
-69%
|
84
+703%
|
71
-15%
|
(52)
N/A
|
(26)
+50%
|
(46)
-76%
|
(27)
+42%
|
18
N/A
|
10
-48%
|
(1)
N/A
|
(0)
+67%
|
6
N/A
|
39
+548%
|
(8)
N/A
|
|
| Free Cash Flow | ||||||||||||||||||
| Free Cash Flow |
(65)
N/A
|
(72)
-10%
|
(92)
-29%
|
(116)
-25%
|
(118)
-2%
|
(131)
-11%
|
(129)
+2%
|
(102)
+21%
|
(100)
+2%
|
(81)
+19%
|
(82)
-2%
|
(92)
-11%
|
(89)
+3%
|
(107)
-20%
|
(89)
+16%
|
(91)
-2%
|
(97)
-7%
|
|
Switch to:
Switch to:
See Also
Discover More
